Literature DB >> 19172987

Chromosome 13q13-q14 locus overlaps mood and psychotic disorders: the relevance for redefining phenotype.

Michel Maziade1, Yvon C Chagnon, Marc-André Roy, Alexandre Bureau, Alain Fournier, Chantal Mérette.   

Abstract

The nosology of major psychoses is challenged by the findings that schizophrenia (SZ) and bipolar disorder (BP) share several neurobiological, neuropsychological and clinical phenotypic characteristics. Moreover, several vulnerability loci or genes may be common to the two DSM disorders. We previously reported, in a sample of 21 kindreds (sample 1), a genome-wide suggestive linkage in 13q13-q14 with a common locus (CL) phenotype that crossed the diagnostic boundaries by combining SZ, BP and schizoaffective disorders. Our objectives were to test phenotype specificity in a separate sample (sample 2) of 27 kindreds from Eastern Quebec and to also analyze the combined sample of 48 kindreds (1274 family members). We performed nonparametric and parametric analyses and tested as phenotypes: SZ alone, BP alone, and a CL phenotype. We replicated in sample 2 our initial finding with CL with a maximum NPL(pair) score of 3.36 at D13S1272 (44 Mb), only 2.1 Mb telomeric to our previous maximum result. In the combined sample, the peak with CL was at marker D13S1297 (42.1 Mb) with a NPL(pair) score reaching 5.21, exceeding that obtained in each sample and indicating consistency across the two samples. Our data suggest a susceptibility locus in 13q13-q14 that is shared by schizophrenia and mood disorder. That locus would be additional to another well documented and more distal 13q locus where the G72/G30 gene is mapped.

Entities:  

Mesh:

Year:  2009        PMID: 19172987      PMCID: PMC2986555          DOI: 10.1038/ejhg.2008.268

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  66 in total

1.  Faster linkage analysis computations for pedigrees with loops or unused alleles.

Authors:  A A Schäffer
Journal:  Hum Hered       Date:  1996 Jul-Aug       Impact factor: 0.444

2.  Suggestive linkage to chromosomal regions 13q31 and 22q12 in families with psychotic bipolar disorder.

Authors:  James B Potash; Peter P Zandi; Virginia L Willour; Tsuo-Hung Lan; Yuqing Huo; Dimitrios Avramopoulos; Yin Y Shugart; Dean F MacKinnon; Sylvia G Simpson; Francis J McMahon; J Raymond DePaulo; Melvin G McInnis
Journal:  Am J Psychiatry       Date:  2003-04       Impact factor: 18.112

3.  Shared and specific susceptibility loci for schizophrenia and bipolar disorder: a dense genome scan in Eastern Quebec families.

Authors:  M Maziade; M-A Roy; Y C Chagnon; D Cliche; J-P Fournier; N Montgrain; C Dion; J-C Lavallée; Y Garneau; N Gingras; L Nicole; A Pirès; A-M Ponton; A Potvin; H Wallot; C Mérette
Journal:  Mol Psychiatry       Date:  2005-05       Impact factor: 15.992

Review 4.  G72/G30 in schizophrenia and bipolar disorder: review and meta-analysis.

Authors:  Sevilla D Detera-Wadleigh; Francis J McMahon
Journal:  Biol Psychiatry       Date:  2006-04-11       Impact factor: 13.382

Review 5.  Diagnosis and classification of schizophrenia.

Authors:  N C Andreasen; W T Carpenter
Journal:  Schizophr Bull       Date:  1993       Impact factor: 9.306

6.  Three potential susceptibility loci shown by a genome-wide scan for regions influencing the age at onset of mania.

Authors:  Stephen V Faraone; Stephen J Glatt; Jessica Su; Ming T Tsuang
Journal:  Am J Psychiatry       Date:  2004-04       Impact factor: 18.112

7.  Strategies for multilocus linkage analysis in humans.

Authors:  G M Lathrop; J M Lalouel; C Julier; J Ott
Journal:  Proc Natl Acad Sci U S A       Date:  1984-06       Impact factor: 11.205

8.  Linkage of a bipolar disorder susceptibility locus to human chromosome 13q32 in a new pedigree series.

Authors:  S H Shaw; Z Mroczkowski-Parker; T Shekhtman; M Alexander; R A Remick; A D Sadovnick; S L McElroy; P E Keck; J R Kelsoe
Journal:  Mol Psychiatry       Date:  2003-05       Impact factor: 15.992

9.  Clinical diagnoses in young offspring from eastern Québec multigenerational families densely affected by schizophrenia or bipolar disorder.

Authors:  M Maziade; N Gingras; N Rouleau; S Poulin; V Jomphe; M-E Paradis; C Mérette; M-A Roy
Journal:  Acta Psychiatr Scand       Date:  2007-11-19       Impact factor: 6.392

10.  Genome scan meta-analysis of schizophrenia and bipolar disorder, part II: Schizophrenia.

Authors:  Cathryn M Lewis; Douglas F Levinson; Lesley H Wise; Lynn E DeLisi; Richard E Straub; Iiris Hovatta; Nigel M Williams; Sibylle G Schwab; Ann E Pulver; Stephen V Faraone; Linda M Brzustowicz; Charles A Kaufmann; David L Garver; Hugh M D Gurling; Eva Lindholm; Hilary Coon; Hans W Moises; William Byerley; Sarah H Shaw; Andrea Mesen; Robin Sherrington; F Anthony O'Neill; Dermot Walsh; Kenneth S Kendler; Jesper Ekelund; Tiina Paunio; Jouko Lönnqvist; Leena Peltonen; Michael C O'Donovan; Michael J Owen; Dieter B Wildenauer; Wolfgang Maier; Gerald Nestadt; Jean-Louis Blouin; Stylianos E Antonarakis; Bryan J Mowry; Jeremy M Silverman; Raymond R Crowe; C Robert Cloninger; Ming T Tsuang; Dolores Malaspina; Jill M Harkavy-Friedman; Dragan M Svrakic; Anne S Bassett; Jennifer Holcomb; Gursharan Kalsi; Andrew McQuillin; Jon Brynjolfson; Thordur Sigmundsson; Hannes Petursson; Elena Jazin; Tomas Zoëga; Tomas Helgason
Journal:  Am J Hum Genet       Date:  2003-06-11       Impact factor: 11.025

View more
  8 in total

1.  Some capabilities for model-based and model-free linkage analysis using the program package S.A.G.E. (Statistical Analysis for Genetic Epidemiology).

Authors:  A H Schnell; X Sun; R P Igo; R C Elston
Journal:  Hum Hered       Date:  2011-12-23       Impact factor: 0.444

2.  Symptom dimensions as alternative phenotypes to address genetic heterogeneity in schizophrenia and bipolar disorder.

Authors:  Aurélie Labbe; Alexandre Bureau; Isabel Moreau; Marc-André Roy; Yvon Chagnon; Michel Maziade; Chantal Merette
Journal:  Eur J Hum Genet       Date:  2012-04-25       Impact factor: 4.246

3.  Follow-up of a major psychosis linkage site in 13q13-q14 reveals significant association in both case-control and family samples.

Authors:  Alexandre Bureau; Yvon C Chagnon; Jordie Croteau; Alain Fournier; Marc-André Roy; Thomas Paccalet; Chantal Mérette; Michel Maziade
Journal:  Biol Psychiatry       Date:  2013-04-18       Impact factor: 13.382

4.  Young offspring at genetic risk of adult psychoses: the form of the trajectory of IQ or memory may orient to the right dysfunction at the right time.

Authors:  Michel Maziade; Nancie Rouleau; Caroline Cellard; Marco Battaglia; Thomas Paccalet; Isabel Moreau; Valérie Gagnon; Nathalie Gingras; Cecilia Marino; Elsa Gilbert; Marc-André Roy; Chantal Mérette
Journal:  PLoS One       Date:  2011-04-29       Impact factor: 3.240

Review 5.  Clinical and molecular genetics of psychotic depression.

Authors:  Katharina Domschke
Journal:  Schizophr Bull       Date:  2013-03-19       Impact factor: 9.306

6.  Verbal and visual memory impairments among young offspring and healthy adult relatives of patients with schizophrenia and bipolar disorder: selective generational patterns indicate different developmental trajectories.

Authors:  Michel Maziade; Nancie Rouleau; Chantal Mérette; Caroline Cellard; Marco Battaglia; Cecilia Marino; Valérie Jomphe; Elsa Gilbert; Amélie Achim; Roch-Hugo Bouchard; Thomas Paccalet; Marie-Eve Paradis; Marc-André Roy
Journal:  Schizophr Bull       Date:  2010-04-21       Impact factor: 9.306

7.  Treatment of psychotic symptoms in bipolar disorder with aripiprazole monotherapy: a meta-analysis.

Authors:  Konstantinos N Fountoulakis; Xenia Gonda; Eduard Vieta; Frank Schmidt
Journal:  Ann Gen Psychiatry       Date:  2009-12-31       Impact factor: 3.455

8.  Linkage replication for chromosomal region 13q32 in schizophrenia: evidence from a Brazilian pilot study on early onset schizophrenia families.

Authors:  Ary Gadelha; Vanessa Kiyomi Ota; Jose Paya Cano; Maria Isabel Melaragno; Marilia A C Smith; Jair de Jesus Mari; Rodrigo A Bressan; Sintia Iole Belangero; Gerome Breen
Journal:  PLoS One       Date:  2012-12-31       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.